211 related articles for article (PubMed ID: 35441136)
21. Genetically predicted circulating levels of glycine, glutamate, and serotonin in relation to the risks of three major neurodegenerative diseases: A Mendelian randomization analysis.
Li R; Deng M; Lin Y; Gao W; Liu B; Xia H
Front Aging Neurosci; 2022; 14():938408. PubMed ID: 36158554
[TBL] [Abstract][Full Text] [Related]
22. Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.
Ning J; Huang SY; Chen SD; Zhang YR; Huang YY; Yu JT
J Alzheimers Dis; 2022; 87(1):211-222. PubMed ID: 35275534
[TBL] [Abstract][Full Text] [Related]
23. Physical activity and amyotrophic lateral sclerosis: a Mendelian randomization study.
Zhang G; Zhang L; Tang L; Xia K; Huang T; Fan D
Neurobiol Aging; 2021 Sep; 105():374.e1-374.e4. PubMed ID: 34023151
[TBL] [Abstract][Full Text] [Related]
24. Causality of genetically determined metabolites on anxiety disorders: a two-sample Mendelian randomization study.
Xiao G; He Q; Liu L; Zhang T; Zhou M; Li X; Chen Y; Chen Y; Qin C
J Transl Med; 2022 Oct; 20(1):475. PubMed ID: 36266699
[TBL] [Abstract][Full Text] [Related]
25. Bi-directional causal effect between vitamin B12 and non-alcoholic fatty liver disease: Inferring from large population data.
Fu L; Wang Y; Hu YQ
Front Nutr; 2023; 10():1015046. PubMed ID: 36950332
[TBL] [Abstract][Full Text] [Related]
26. Association Between Premorbid Body Mass Index and Amyotrophic Lateral Sclerosis: Causal Inference Through Genetic Approaches.
Zeng P; Yu X; Xu H
Front Neurol; 2019; 10():543. PubMed ID: 31178821
[No Abstract] [Full Text] [Related]
27. Peripheral immune markers and amyotrophic lateral sclerosis: a Mendelian randomization study.
Hu Z; Zuo C; Mao C; Shi C; Xu Y
Front Neurosci; 2023; 17():1269354. PubMed ID: 38188028
[TBL] [Abstract][Full Text] [Related]
28. Assessment of causal effects of physical activity on neurodegenerative diseases: A Mendelian randomization study.
Wu PF; Lu H; Zhou X; Liang X; Li R; Zhang W; Li D; Xia K
J Sport Health Sci; 2021 Jul; 10(4):454-461. PubMed ID: 33515719
[TBL] [Abstract][Full Text] [Related]
29. Neurodegenerative disease and antioxidant biomarkers: A bidirectional Mendelian randomization study.
Zhang Q; Li Q; Zhao H; Shu M; Luo M; Li Y; Ding Y; Shi S; Cheng X; Niu Q
Front Neurol; 2023; 14():1158366. PubMed ID: 37034095
[TBL] [Abstract][Full Text] [Related]
30. Assessing the Causal Role of Selenium in Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study.
He D; Cui L
Front Genet; 2021; 12():724903. PubMed ID: 34691149
[No Abstract] [Full Text] [Related]
31. Physical activities and risk of neurodegenerative diseases: A two-sample Mendelian randomization study.
Liao Q; He J; Huang K
Front Aging Neurosci; 2022; 14():991140. PubMed ID: 36212040
[TBL] [Abstract][Full Text] [Related]
32. Polygenic associations and causal inferences between serum immunoglobulins and amyotrophic lateral sclerosis.
Chen X; Shen X; Zhang X; Zhan Y; Fang F
Clin Chim Acta; 2021 Oct; 521():131-136. PubMed ID: 34245689
[TBL] [Abstract][Full Text] [Related]
33. Cortical structure and the risk of amyotrophic lateral sclerosis: A bidirectional Mendelian randomization study.
Jia H; Li Z; Guo F; Hua Z; Zhou X; Li X; Li R; Liu Q; Liu Y; Dong H
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Feb; 129():110872. PubMed ID: 37827425
[TBL] [Abstract][Full Text] [Related]
34. Genetically predicted levels of folate, vitamin B
Yang H; Song J; Li A; Lv L; Sun X; Mao Y; Ye D
Front Immunol; 2023; 14():1139799. PubMed ID: 36969181
[TBL] [Abstract][Full Text] [Related]
35. Type 2 Diabetes Mellitus and Amyotrophic Lateral Sclerosis: Genetic Overlap, Causality, and Mediation.
Chen H; Zhang J; Wang T; Zhang S; Lai Q; Huang S; Zeng P
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4497-e4508. PubMed ID: 34171091
[TBL] [Abstract][Full Text] [Related]
36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-1 receptor antagonist, interleukin-2 receptor alpha subunit and amyotrophic lateral sclerosis.
Yuan S; Roos PM; Larsson SC
Eur J Neurol; 2020 Oct; 27(10):1913-1917. PubMed ID: 32441415
[TBL] [Abstract][Full Text] [Related]
38. Association Between C-Reactive Protein and Risk of Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study.
Zhu Y; Li M; Zhang J; Huang X
Front Genet; 2022; 13():919031. PubMed ID: 35669191
[No Abstract] [Full Text] [Related]
39. Lipids and amyotrophic lateral sclerosis: A two-sample Mendelian randomization study.
Xia K; Klose V; Högel J; Huang T; Zhang L; Dorst J; Fan D; Ludolph AC
Eur J Neurol; 2023 Jul; 30(7):1899-1906. PubMed ID: 36999624
[TBL] [Abstract][Full Text] [Related]
40. Assessing Causal Relationship Between Human Blood Metabolites and Five Neurodegenerative Diseases With GWAS Summary Statistics.
Chen H; Qiao J; Wang T; Shao Z; Huang S; Zeng P
Front Neurosci; 2021; 15():680104. PubMed ID: 34955704
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
